Haemonetics Publishes Inaugural Corporate Responsibility Report

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) announced the release of its first Corporate Responsibility Report on April 20, 2023. The report outlines the company's progress in environmental, social, and governance (ESG) initiatives for the fiscal year 2022, concluding on April 2, 2022. Key highlights include:

• Human capital initiatives aimed at attracting a diverse workforce.
• Results from the company's first greenhouse gas emissions assessment.
• Information on corporate governance, ethics, product safety, and cybersecurity.

CEO Christopher A. Simon emphasized the importance of addressing ESG risks and maintaining stakeholder trust. The report is available on Haemonetics' website.

Positive

• Released inaugural Corporate Responsibility Report, highlighting commitment to ESG.
• Details on workforce diversity initiatives enhancing talent retention.
• First greenhouse gas emissions assessment indicating environmental responsibility.

Negative

• None.

BOSTON, April 20, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced the release of its 2022 Corporate Responsibility Report. The report outlines key environmental, social and governance (ESG) initiatives of Haemonetics that align with its core values and corporate strategy.

Haemonetics' 2022 Corporate Responsibility report provides data for its fiscal year 2022 that ended on April 2, 2022, unless otherwise indicated, and reports on the company's ESG progress across four pillars: "Growing Our Business Responsibly", "Investing in Our People", "Driving Social Impact" and "Reducing Our Environmental Impact." Highlights from the report include:

• Updates on the company's human capital initiatives designed to attract and retain top talent and foster a diverse and inclusive workforce, including certain workforce diversity data and a link to Haemonetics' latest EEO-1 report.
• Reporting on the company's environmental initiatives, including the results from Haemonetics' first Scope 1 and 2 greenhouse gas emissions assessment, completed in calendar 2022.
• Additional information on the company's programs and practices relating to, among other topics, corporate governance; ethics and compliance; occupational health and safety; technology and innovation; product quality and safety; and cybersecurity.

"As we continue to grow our business, we are guided by our Purpose and mindful of the expectations of our stakeholders whose trust we value," said Christopher A. Simon, Haemonetics' President and Chief Executive Officer. "With our inaugural Corporate Responsibility Report, we are proud to share the steps we are taking to proactively identify and manage ESG risks and opportunities, and to help ensure the long-term health and success of our company, our employees, and the customers and communities we serve."

Haemonetics' 2022 Corporate Responsibility Report is available on the company's website here.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com

David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com

Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-publishes-inaugural-corporate-responsibility-report-301802894.html

SOURCE Haemonetics Corporation

FAQ

What is the significance of Haemonetics' Corporate Responsibility Report 2022?

It marks Haemonetics' commitment to ESG initiatives and stakeholder transparency.

When was Haemonetics' Corporate Responsibility Report released?

The report was released on April 20, 2023.

What are the key areas covered in Haemonetics' 2022 Corporate Responsibility Report?

The report covers human capital initiatives, environmental impacts, and corporate governance.

What are Haemonetics' goals for ESG as outlined in their report?

Haemonetics aims to manage ESG risks and enhance stakeholder trust.

Where can I find Haemonetics' Corporate Responsibility Report?

The report is available on Haemonetics' official website.